Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-04-29Clinical Trial Update: Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer [Phase 3]
Phase 3 trial comparing induction chemotherapy with Taxotere/cisplatin/5-FU (TPF) versus standard cisplatin/5-FU (PF) followed by chemoradia…
-
CLINICAL_TRIALS trial_result · 2009-04-29Clinical Trial Update: Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors [Phase 1]
This is a Phase 1 dose-escalation trial of 2-Deoxy-D-glucose (2DG) in adults with advanced solid tumors, spanning multiple cancer types and …
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma [Phase 2]
Phase 2 trial evaluating gefitinib (IRESSA) in combination with cisplatin and radiotherapy for advanced head and neck cancer; the study stat…
-
CLINICAL_TRIALS trial_result · 2009-03-09Clinical Trial Update: Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy [Phase 2]
Phase 2 trial assessing cetuximab plus cisplatin in patients with metastatic or recurrent head and neck cancer that has not responded to cis…
-
CLINICAL_TRIALS withdrawal · 2009-03-02Clinical Trial Update: A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy [Phase 1, Phase 2]
The trial evaluating palifermin for reducing oral mucositis in locally advanced head and neck cancer patients receiving postoperative radiot…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx [Phase 2]
Phase 2 clinical trial update evaluating combination chemotherapy for nasopharyngeal cancer (Stage IIB/III/IV). The provided information not…
-
CLINICAL_TRIALS research · 2009-02-06Clinical Trial Update: Functional Imaging in HNC Undergoing Chemoradiation
This entry notes a clinical trial exploring functional imaging in head and neck cancer patients undergoing chemoradiation, sponsored by Roya…
-
CLINICAL_TRIALS trial_result · 2009-02-04Clinical Trial Update: Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer [Phase 2]
Phase 2 study evaluating amifostine with IMRT to protect salivary glands in head and neck cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-02Clinical Trial Update: An Exploratory, Open Label, Single Center Study of [F-18]HX4 [EARLY_Phase 1]
An exploratory, open-label Phase 1 study of the radiotracer [F-18]HX4 in head and neck cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-01-27Clinical Trial Update: Doxil Topotecan Doublet Cancer Study [Phase 1]
A Phase 1 trial evaluating a Doxil (liposomal doxorubicin) and topotecan doublet across multiple cancers has completed.
-
CLINICAL_TRIALS trial_result · 2009-01-12Clinical Trial Update: Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib [Phase 1]
Phase 1 pharmacokinetic/pharmacodynamic study evaluating the combination of cetuximab and gefitinib in colorectal cancer, head and neck canc…
-
FDA approval · 2008-11-07FDA Approved: ETHYOL — Supplemental Application (Legacy Pharma USA Inc.)
The FDA approved a supplemental application for ETHYOL (amifostine) submitted by Legacy Pharma USA Inc.
-
CLINICAL_TRIALS research · 2008-10-31Clinical Trial Update: Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.
This clinical trial update describes validation of FDG-PET segmentation tools for delineating tumors by correlating CT- and FDG-PET volume m…
-
CLINICAL_TRIALS trial_result · 2008-10-08Clinical Trial Update: Systemic Ketamine for the Improvement of Post-Operative Analgesia at the Alcohol-Dependent Patient [Phase 3]
A Phase 3 clinical trial evaluating systemic ketamine for improving post-operative analgesia in alcohol-dependent patients has been suspende…
-
CLINICAL_TRIALS research · 2008-07-24Clinical Trial Update: Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer [Phase 2]
A Phase 2 clinical trial evaluating Paclitaxel for recurrent or refractory head and neck cancer; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2008-07-23Clinical Trial Update: Hyperimmune Colostrum and Oral Mucositis [NA]
Update on a clinical trial evaluating hyperimmune colostrum for oral mucositis in head and neck cancer patients; the status of the study is …
-
CLINICAL_TRIALS trial_result · 2008-06-24Clinical Trial Update: Phase II Trial of Allovectin-7® for Head and Neck Cancer [Phase 3]
This clinical trial update announces the completion of a Phase 3 study of Allovectin-7 for head and neck cancer, including squamous cell car…
-
CLINICAL_TRIALS trial_result · 2008-06-10Clinical Trial Update: Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck Cancer
The study to calculate radiation dosimetry in subjects with head and neck cancer has completed.
-
CLINICAL_TRIALS research · 2008-01-29Clinical Trial Update: COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma [Phase 3]
This entry reports on a Phase 3 trial evaluating a COX-2 inhibitor with concurrent chemoradiation for locally advanced head and neck cancer,…
-
CLINICAL_TRIALS trial_result · 2007-12-19Clinical Trial Update: Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck Carcinoma [Phase 2]
Phase 2 trial evaluating gefitinib (Iressa) with or without concurrent chemoradiotherapy in advanced non-nasopharyngeal head and neck cancer…
-
CLINICAL_TRIALS trial_result · 2007-12-18Clinical Trial Update: Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated gefitinib (Iressa) in combination with chemoradiation for locally advanced head and neck cancer; the st…
-
CLINICAL_TRIALS trial_result · 2007-08-10Clinical Trial Update: Can Cytokines Predict the Severity of Acute Mucositis and the Need for Gastrostomy Tubes (PEG)?
A ClinicalTrials.gov update for NCT00431925 from Hadassah Medical Organization, studying whether cytokines can predict the severity of acute…
-
CLINICAL_TRIALS trial_result · 2007-07-20Clinical Trial Update: Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer [Phase 1, Phase 2]
A terminated Phase 1/2 safety trial evaluating IRESSA (gefitinib) with cisplatin and radiation therapy in head and neck cancer patients.
-
CLINICAL_TRIALS trial_result · 2007-05-08Clinical Trial Update: Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer [Phase 1]
Phase 1 trial of motexafin gadolinium combined with chemotherapy and radiation for advanced head and neck cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2007-04-27Clinical Trial Update: The Role of CT-PET-MRI Image Fusion in Determining Radiation Treatment Volumes of Head-and-Neck Cancer Patients [NA]
This update describes a trial investigating CT-PET-MRI image fusion to guide radiation treatment volumes in head and neck cancer patients.